Voyager Therapeutics Inc (VYGR) returns
Voyager Therapeutics returns over 10 years
$1,000 invested in Voyager Therapeutics ten years ago was worth $140.98 at the close on October 30, 2026, with dividends reinvested: an average return of -17.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -35.8% | — | $641.79 | -0.9% |
| 3 months | -45.0% | — | $549.52 | +2.1% |
| Year to date | -56.2% | — | $437.66 | +11.7% |
| 1 year | -61.9% | — | $380.53 | +12.4% |
| 3 years | -73.7% | -35.9% | $263.00 | +88.5% |
| 5 years | -52.5% | -13.8% | $475.14 | +76.0% |
| 10 years | -85.9% | -17.8% | $140.98 | +316.6% |
Voyager Therapeutics return by calendar year
| Year | VYGR | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -56.2% | +11.7% | -67.9% |
| 2025 | -30.7% | +17.7% | -48.4% |
| 2024 | -32.8% | +24.9% | -57.7% |
| 2023 | +38.4% | +26.2% | +12.2% |
| 2022 | +125.1% | -18.2% | +143.3% |
| 2021 | -62.1% | +28.7% | -90.8% |
| 2020 | -48.7% | +18.4% | -67.1% |
| 2019 | +48.4% | +31.2% | +17.2% |
| 2018 | -43.4% | -4.6% | -38.8% |
| 2017 | +30.3% | +21.7% | +8.6% |
| 2016 | -41.8% | +12.0% | -53.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: VYGR financials
No forecast, no recommendation. This page describes Voyager Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.